Ramatroban, also known by the trade name Baynas, is approved and mainly used in Japan for the treatment of allergic rhinitis (hay fever). It works as a dual antagonist, blocking both thromboxane A2 (TP) and prostaglandin D2 (DP2/CRTH2) receptors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Baynas and Ramatrobanum. Its PubChem CID is 123879.
Ramatroban
| CAS No | 116649-85-5 |
|---|---|
| Molecular Formula | C21H21FN2O4S |
| Molecular Weight | 416.5 g/mol |
| Synonyms | 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ramatroban, also known by the trade name Baynas, is approved and mainly used in Japan for the treatment of allergic rhinitis (hay fever). It works as a dual antagonist, blocking both thromboxane A2 (TP) and prostaglandin D2 (DP2/CRTH2) receptors.
The listed CAS number is 116649-85-5.
The listed molecular formula is C21H21FN2O4S.
The listed molecular weight is 416.5 g/mol.
3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid.
The source lists Baynas and Ramatrobanum.